Drug Profile
AP 48
Latest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator ALZA Corporation
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 22 Oct 2004 Discontinued - Phase-III for Pain in USA (Transdermal)
- 17 Oct 2003 Phase-III clinical trials in Pain in USA (unspecified route)